Esta compañía no ha anunciado ningún dividendo en el próximo trimestre, ni ha pagado dividendos en el último año.
Sobre MediWound Ltd.
MediWound Ltd. is a biopharmaceutical company, which engages in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product is NexoBrid. The company was founded by Lior Rosenberg and Marian Gorecki in January 2000 and is headquartered in Yavne, Israel.